Disclosure 0001193125-26-355493-1

SEC FORM 4

$349,733.58

Relay Therapeutics, Inc. (RLAY)

Sale of 17,717 shares at $19.74 per share.

Reporting Person Catinazzo Thomas · Officer Title Chief Financial Officer · Transaction Code S

Traded Aug 14, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0001193125-26-355493 · filed 2026-08-18 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Relay Therapeutics, Inc. (RLAY)." Disclosed 2026-08-18. https://desqlong.com/cards/0001193125-26-355493-1 (retrieved 2026-09-26).